Pro Medicus Limited
PME
Rang in Aktien
#1639
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Aktienkurs
$125.52
Marktkapitalisierung
$13.11B
Veränderung (1 Tag)
3.30%
Veränderung (1 Jahr)
-32.39%
Land
AU
Handel Pro Medicus Limited (PME)
Kategorie
Healthcare
EPS für Pro Medicus Limited (PME)
EPS zum June 2026 TTM: $1.79
Laut den aktuellen Finanzberichten und dem Aktienkurs von Pro Medicus Limited beträgt das aktuelle EPS des Unternehmens (TTM) $1.79. Am Ende des Jahres 2024 betrug das EPS $0.53 eine Steigerung gegenüber dem EPS von 2023, das $0.39 betrug.
EPS-Verlauf von Pro Medicus Limited von 2000 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $1.79 | 148.81% |
| 2025 | $0.72 | 37.27% |
| 2024 | $0.53 | 36.52% |
| 2023 | $0.39 | 30.28% |
| 2022 | $0.30 | 31.88% |
| 2021 | $0.22 | 48.16% |
| 2020 | $0.15 | 20.09% |
| 2019 | $0.13 | 76.78% |
| 2018 | $0.07 | 2.00% |
| 2017 | $0.07 | 49.79% |
| 2016 | $0.05 | 89.47% |
| 2015 | $0.02 | 73.94% |
| 2014 | $0.01 | -69.66% |
| 2013 | $0.05 | 154.35% |
| 2012 | $0.02 | 240.74% |
| 2011 | $0.01 | -83.64% |
| 2010 | $0.03 | -28.42% |
| 2009 | $0.05 | -39.18% |
| 2008 | $0.08 | 25.70% |
| 2007 | $0.06 | 33.11% |
| 2006 | $0.05 | 8.37% |
| 2005 | $0.04 | 67.87% |
| 2004 | $0.02 | -17.55% |
| 2003 | $0.03 | 11.85% |
| 2002 | $0.03 | 29.81% |
| 2001 | $0.02 | 5.58% |
| 2000 | $0.02 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $3.48 | 94.26% |
US
|
|
| $1.43 | -20.17% |
US
|
|
| $-1.43 | -179.83% |
US
|
|
| $-0.59 | -132.94% |
US
|
|
| - | - |
US
|
